Michael Chastain
Impact in
- Virology top 5%
- HIV Research and Treatment
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
-
- RNA and protein synthesis mechanisms 3
- RNA Interference and Gene Delivery 3
- RNA Research and Splicing 2
- Genetics 9
- Virus-based gene therapy research 9
- Co-authors
- Ignacio Tinoco (4 shared papers)Jacqueline R. Wyatt (1 shared paper)Joseph D. Puglisi (1 shared paper)John W. Shiver (7 shared papers)Jeffrey Chou (2 shared papers)David R. Minor (2 shared papers)Abraham Anderson (2 shared papers)Howard L. Kaufman (2 shared papers)
- Journals
- Journal of Virology (3 papers)Journal of Clinical Oncology (3 papers)Vaccine (3 papers)Biochemistry (2 papers)Molecular Therapy (1 paper)
- Partner nations
- United StatesItalyJapan
In The Last Decade
Michael Chastain
21 papers receiving 1.9k citations
Michael Chastain's Hit Papers
Peers
Comparison fields: 5 of 79
- Virology 198
- Immunology 562
- Oncology 492
- Genetics 407
- Epidemiology 445
Countries citing papers authored by Michael Chastain
This map shows the geographic impact of Michael Chastain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Chastain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Chastain more than expected).
Fields of papers citing papers by Michael Chastain
This network shows the impact of papers produced by Michael Chastain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Chastain. The network helps show where Michael Chastain may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Chastain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma Hit paper breakdown → | 2016 | 462 |
| 2 | 2004 | 285 | |
| 3 | Synthesis and purification of large amounts of RNA oligonucleotides. | 1991 | 172 |
| 4 | 1991 | 123 | |
| 5 | 1999 | 120 | |
| 6 | 2008 | 115 | |
| 7 | 2010 | 111 | |
| 8 | 2007 | 96 | |
| 9 | 2004 | 85 | |
| 10 | 2014 | 71 | |
| 11 | 2005 | 65 | |
| 12 | 1992 | 40 | |
| 13 | 2002 | 39 | |
| 14 | 2004 | 36 | |
| 15 | 2001 | 34 | |
| 16 | 1993 | 23 | |
| 17 | 1992 | 19 | |
| 18 | 2008 | 16 | |
| 19 | 2015 | 13 | |
| 20 | 2006 | 5 |
About Michael Chastain
Michael Chastain is a scholar working on Molecular Biology, Genetics, Virology, Immunology and Oncology, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), HIV Research and Treatment (5 papers), CAR-T cell therapy research (4 papers), RNA and protein synthesis mechanisms (3 papers), RNA Interference and Gene Delivery (3 papers), Cancer Research and Treatments (3 papers), Immune Response and Inflammation (3 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Virology (198 citations), Immunology (562 citations), Oncology (492 citations), Genetics (407 citations) and Epidemiology (445 citations). Michael Chastain has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Ignacio Tinoco, Jacqueline R. Wyatt, Joseph D. Puglisi, John W. Shiver, Jeffrey Chou, David R. Minor, Abraham Anderson, Howard L. Kaufman, Omid Hamid and Igor Puzanov. Their work appears in journals such as Journal of Virology, Journal of Clinical Oncology, Vaccine, Biochemistry and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.